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Abstract
Background: Identification of receptor mediated signaling pathways in embryonic stem (ES) cells is needed to facilitate
strategies for cell replacement using ES cells. One large receptor family, largely uninvestigated in ES cells, is G protein
coupled receptors (GPCRs). An important role for these receptors in embryonic development has been described, but little
is known about GPCR expression in ES cells.
Methodology/Principal Findings: We have examined the expression profile of 343 different GPCRs in mouse ES cells
demonstrating for the first time that a large number of GPCRs are expressed in undifferentiated and differentiating ES cells,
and in many cases at high levels. To begin to define a role for GPCR signaling in ES cells, the impact of activating Gs-alpha,
one of the major alpha subunits that couples to GPCRs, was investigated. Gs-alpha activation resulted in larger embryoid
bodies (EBs), due, in part, to increased cell proliferation and prevented the time-related decline in expression of transcription
factors important for maintaining ES cell pluripotency.
Significance/Conclusions: These studies suggest that Gs-alpha signaling contributes to ES cell proliferation and
pluripotency and provide a framework for further investigation of GPCRs in ES cells.
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Introduction
In embryonic stem (ES) cells, receptor mediated signaling
pathways are important for maintaining pluripotency [1,2], a state
characterized by the ability of ES cells to differentiate into cell
types from all three germ layers [2,3]. Signaling through the
leukemia inhibitory factor (LIF) receptor in murine ES cells and a
bone morphogenetic factor (BMP) receptor in human ES cells is
important for pluripotency [2,4], although additional pathways
play critical roles [5]. Similarly, ES cell differentiation pathways
are typically directed, in part, by sequential activation of receptor-
mediated intracellular signaling pathways by peptides and other
molecules [6,7,8]. Improved understanding of receptor-stimulated
signaling pathways that contribute to ES cell pluripotency and
differentiation will ultimately facilitate regenerative therapies.
G protein coupled receptors (GPCRs) are a large class of
transmembrane receptors that transmit extracellular signals into
cells by coupling to guanine nucleotide binding proteins (G
proteins) and play a key role in many complex biological processes,
including development [9–11]. For example, roles for apelin and
its corresponding GPCR in cardiovascular development, GPR161
in lens development and left-right patterning, and PAR1, a
protease-activated GPCR for thrombin, in endothelial signaling
during development have been demonstrated [12–15]. Moreover,
global knockout of some GPCRs and/or components of their
signaling pathways are embryonic lethal or associated with
significant developmental anomalies in mice and humans [16].
Despite the importance of GPCRs in development, with the
exception of the Frizzled receptors [17], the role of GPCRs in ES
cell pluripotency and differentiation has received little attention
[18]. Since GPCRs are readily targetable sites for small molecules,
as evidenced by their role as drug targets in humans [9],
characterization of GPCRs and related signaling molecules in
ES cells may facilitate developing new approaches to ES cell
differentiation. Given that, one of the goals of this study was to
examine GPCR expression in ES cells.
GPCRs signal through ,20 internal G protein alpha subunits.
One of these alpha subunits, the stimulatory alpha subunit of G-
proteins (Gs-alpha), activates the cAMP pathway, a well described
pathway which is important in multiple complex processes,
including cell proliferation and differentiation. Gs-alpha is also
important during development, as mice with heterozygous,
homozygous, and tissue specific knockouts of Gs-alpha exhibit
significant developmental abnormalities and lethality [19]. The
role of Gs-alpha in stem cell biology was demonstrated more
directly via its importance for haematopoietic stem cell engraft-
ment in bone marrow [20]. Again, despite its importance in
development, the role of signaling through Gs-alpha in ES cell
biology has not been examined.
In this study, we profiled the expression of hundreds of GPCRs in
both undifferentiated and differentiated ES cells using a GPCR-
specific real time RT-PCR microarray specific for 343 GPCRs and
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strated for the first time expression of novel GPCRs in
undifferentiated and differentiated ES cells and, in some cases,
differential expression during ES cell differentiation. We also tested
whether signaling through Gs-alpha plays a role in ES cell biology
f i n d i n gt h a tG s - a l p h aa c t i v a t i o nl e a d st ol a r g ee m b r y o i db o d i e s
(EBs), in part by enhancing the proliferation rate of cells within EBs.
We also tested whether signaling through Gs-alpha impacts ES cell
pluripotency and differentiation, and demonstrated that this G
protein signaling pathway alters the expression of transcription
factors important for maintaining ES cell pluripotency.
Methods
ES Cell Culture
The R1 mouse ES cell line was used, and mouse embryonic
fibroblasts (MEFs) were prepared as described previously [21].
Undifferentiated ES cells were grown on irradiated mouse MEFs
with knockout-DMEM (Invitrogen, Carlsbad, CA) supplemented
with 20% serum knockout serum replacement (Invitrogen), 10
3 U/
ml leukemia inhibitory factor (LIF), 0.1 mM non-essential amino
acids, 2 mM glutamine, 500 U/ml penicillin/streptomycin, and
0.55 mM 2-mercaptoethanol [22]. ES cells were detached from the
dishes using 0.05% trypsin-EDTA and then grown in suspension
culture in 60620 mm petri dishes (Nunc, Rochester, NY) at an initial
density of ,4610
5 cells/ml of knockout-DMEM without LIF to
facilitate formation of EBs. Four days after initiating growth in
suspension, medium changes were performed every 2 days. For
experiments with cholera toxin (CTX), the medium was supple-
mented with CTX (1 mg/ml). EB formation was allowed to occur
over a 4-day period, and, following EB formation, the medium was
changed every 2 days. To generate feeder layer independent R1 ES
cells, ES cells were grown on gelatin plates for 5–6 passages without
MEFs in the presence of LIF as previously described [23]. For EB
formation in hanging drops, ES cells were trypsinized and counted
using standard protocols, and cells were either resuspended in
medium without or with CTX (1 mg/ml). Drops (500 cells/20 ml
drop) were placed and allowed to grow for 2 days. The EBs were
then transferred individually into a 96 well plate (non-coated) for
continued growth [24].
Quantification of Embryoid Body Size
EBs were examined every 4 days using light microscopy, and
images were obtained to determine EB diameter. Digital images
were acquired using a Spot camera, and the accompanying image
analysis software (Diagnostic Instruments, Inc., Sterling Heights,
MI) attached to a Nikon Eclipse 50i microscope (Nikon, Tokyo,
Japan) was used to process the images.
Table 1. Real-time RT-PCR primers (forward and reverse
sequences).
Markers Forward Reverse
Nanog ctcttcaaggcagccctgat ccattgctagtcttcaaccac
Oct4 ggcgttctctttggaaaggtg ctcgaaccacatccttctct
E-Cadherin aaacttggggacagcaacatcag tcttttggtttgcagagacaggg
Brachyury catgtactctttcttgctgg ggtctcgggaaagcagtggc
Mixl1 gcacgtcgttcagctcggagcagc agtcatcctgggatccggaacgtgg
Sox17 ttggaacctccagtaagccag agatgtctggaggtgctgctcatt
Fox2A caggtcggggtcttgggagtgc ggaggagggggccgaagaacc
Cxcr4 cgggatgaaaacgtccattt atgaccaggatcaccaatcca
Beta-actin accaactgggacgatatggagaaga tacgaccagaggcatacagggacaa
Mc4R acagcgagtctcagggaaaa ttgaccagtctgctgtttgc
SSTR1 ctactgtctgactgtgct atgggcaagataaccagtaat
LPA2 cactcagcctagtcaagacggtt gcatctcgggaatataccact
GPR108 cgagctgacatccaactgaa gatgaggaacaggaccagga
GLP-1 gggtctctggctacataaggacaac aaggatggctgaagcgatgac
doi:10.1371/journal.pone.0009105.t001
Figure 1. Changes in mRNA levels for markers of pluripotency and the three germ cell layers in undifferentiated ES cells relative to
EBs at day 4 and day 20. (A) Relative changes in the level of mRNA encoding markers of pluripotency, Nanog and Oct4, during EB differentiation at
day 4 (blue) and at day 20 (red) as compared to undifferentiated ES cells (green). Values are the mean 6 SEM (n=5 for Nanog and n=4 for Oct4) of
the relative level of mRNA in day 4 and day 20 EBs compared to the level in undifferentiated ES cells which was defined as 1.0. (B) Relative changes in
the level of mRNA encoding markers of the three germ layers; mesoderm (Brachyury), endoderm (CXCR4), and ectoderm (Nestin) during EB
differentiation, at day 4 (blue) and at day 20 (red), as compared to the level of mRNA in undifferentiated ES cells (green). Values are the mean 6 SEM
(n=4 for Brachyury, n=3 for CXCR4, and n=3 for Nestin) of the level of mRNA in day 4 and day 20 EBs compared to the level in undifferentiated ES
cells, which was defined as 1.0.
doi:10.1371/journal.pone.0009105.g001
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Cells were isolated and lysed using Trizol reagent (Invitrogen).
Total RNA was isolated, DNA removed by DNAase I (Ambion,
Applied Biosystems, Carlsbad, California) digestion, and cDNA was
prepared with the iScript cDNA synthesis kit (BioRad, Hercules,
CA). Samples were run at a 1/5 to 1/40 dilution using SYBR green
master mix (Qiagen, Valencia, CA). Real time RT-PCR was
performed on a 96 well iCycler iQ5 (BioRad). mRNAs encoding
markers of pluripotency (Nanog, Oct4), ectoderm (E-Cadherin,
Nestin), mesoderm (Brachyury, Mixl1), and endoderm (Sox17,
Fox2A and Cxcr4) were examined by real time RT-PCR, and the
level of the different mRNAs was normalized to the level of the
housekeeping gene, beta-actin (see Table 1 for primer sequences). A
comparative Ct (cycle time) analysis was utilized to determine fold
change in RNA expression based on the DDCt approach [25].
GPCR RNA Arrays
A commercially-available TaqMan real time RT-PCR GPCR
384-well microarray (Applied Biosystems, Carlsbad, California)
which allows the expression of mRNAs encoding GPCRs from 50
different subfamilies (343 receptors, not including the odorant,
olfactory, gustatory and pheromone receptors) to be quantified
was used with RNA extracted from day 4 and 20 EBs, as well as
undifferentiated ES cells grown for 5 passages in a feeder
independent culture. For this assay, cDNA was prepared as
described above, and each port was loaded with cDNA (from 1 mg
of RNA) and the TaqMan Gene Expression Master Mix (Applied
Biosystems) according to the manufacturer’s instructions. The
plate was analyzed on the 7900HT ABI PRISM in the
Northwestern University Genomics Core. The results of the assay
were analyzed using SDS2.3 and RQ Manager 1.2 software
provided by Applied Biosystems. Cycle times were normalized to
the house keeping gene beta-2 microglobulin. A comparative Ct
approach was utilized to quantify the relative levels of mRNA [25]
and computed using the RQ 1.2 software. Relative expression
level was calculated as 2
(Ct GPCR–Ct control)610
5. The results of
each individual GPCR were examined, and if the sample had a
calculated threshold less than 0.1, it was determined to be
Figure 2. GPCR expression in ES cells using a real time RT-PCR microarray. (A) The level of mRNA encoding GPCRs from day 4 (blue) and
day 20 (red) EBs and undifferentiated ES cells (green) was categorized as undetectable, low, medium, and high. The cycle number (Ct) for the low,
medium, and high groups were greater than 31.0, 31.0–28.0, and less than 28.0, respectively. Ct values for each GPCR were the average of the results
from 2 independent experiments. (B) Receptors with the highest level of expression in day 4 EBs are indicated with their corresponding relative level
of expression and gene name. The relative expression is presented as 2
Ct (GPCR)–Ct (housekeeping gene)610
5. (C) Receptors with the highest level of
expression in day 20 EBs are indicated with their corresponding relative level of expression and gene name. The relative expression is presented as
2
Ct (GPCR)–Ct (housekeeping gene)610
5. (D) Receptors with the highest level of expression in undifferentiated ES cells are indicated with their
corresponding relative level of expression and gene name. The relative expression is presented as 2
Ct (GPCR)–Ct (housekeeping gene)610
5.
doi:10.1371/journal.pone.0009105.g002
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cycle number was set at 40.0.
Western Blot Analysis
EBs were isolated in RIPA cell lysis buffer containing a cocktail
of protease inhibitors (Protease Inhibitors and Phosphatase
Inhibitors mixes used as recommended, Calbiochem, LaJolla,
CA) at different time points. Primary antibodies were obtained
from Cell Signaling, except for antibodies directed against Nanog
(Applied Biosystems), melanocortin-4 receptor (MC4R, Santa
Cruz, Santa Cruz, CA) and Gs-alpha (Calbiochem). The protein
content of the lysate was determined using the Coomassie blue
protein assay. Thirty micrograms of protein were separated by
10% SDS-PAGE and transferred to a polyvinylidene difluoride
membrane in a semidry apparatus. The membranes were blocked
in 20 mM Tris (pH 7.6), 137 mM NaCl, and 0.1% Tween 20
(TBS-T) and 4% nonfat dry milk for 60 min at room temperature.
Membranes were incubated overnight at 4uC in TBS-T containing
5% BSA and primary antibody, washed three times for 10 min at
room temperature in TBS-T, and incubated for 60 min at room
temperature in TBS-T containing 4% nonfat dry milk and
secondary antibody (1:4000 dilution). After three washes in TBS-
T, immunoreactive bands were detected using the enhanced
chemiluminescence detection system from Amersham Pharmacia
Biotech (Arlington Heights, IL), according to the manufacturer’s
instructions.
Immunofluorescence Analyses
EBs were isolated on different days over a 20 day period and
fixed by washing with 1X PBS at room temperature (RT),
incubating in 4% paraformaldehyde (PFA) for 30 min at RT,
washing again with 1X PBS and then adding 80% ethanol prior to
embedding. To quantify cells which expressed Nanog, EBs were
Table 2. GPCRs that were upregulated in day 20 compared to
day 4 EBs.
Family Gene
Fold
Change Family Gene
Fold
Change
PACAP Adcyap1r1 306 Orphans (cont) Gpr87 7
Adenosine Adora1 56 Gpr26 12
Adora2a 10 Lphn1 7
Angiotensin Agtr2 18 Lphn3 73
Adrenoceptor Adra2a 33 Glutamate Grm2 6
Adrb1 18 Grm3 202
Avpr1b 11 Grm4 41
Vasopressin CCr10 12 Grm5 135
Crcp 5 Grm8 169
Calcitonin Celsr2 79 Orexin Hcrt1 4
Cadherin Celsr3 6 Histamine Hrh1 9
Acetylcholine Chrm3 9 Hrh2 6
Chrm5 68 Hrh3 13
Cannaboid Cnr1 13 Serotonin Htr1b 4
Dopamine Drd2 20 Htr2a 11
Endothelin Ednrb 34 Htr2c 6
Frizzled Frzb 83 Htr4 35
Fzd1 12 Kisspeptins Kiss1r 8
GABA Gabbr1 12 Leucine-rich Lgr5 36
Gabbr2 1083 Lgr6 4
Glucagon Ghsr 9 Melanocortin Mc4r 377
Gipr 6 Mchr1 92
Orphans Gpr123 5 Neuropeptide FF Npffr1 10
Gpr34 5 Opoiod Oprk1 6
Gpcr5b 5 Oprl1 6
Gpr139 236 Oprm1 10
Gpr22 131 Purinergic P2ry1 6
Gpr45 453 PTH Pthr1 4
Gpr50 23 Rhodopsin Rrh 12
Gpr149 5 Somatostatin Sstr1 422
Gpr156 32 Sstr2 5
Gpr162 29 Sstr5 5
Gpr176 9 Tachykinin Tacr1 86
Gpr160 4 Tacr3 82
Gpr62 8 Luteinizing Lhcgr 26
Gpr63 6 Neuromedin U Nmur2 10
Gpr85 6
GPCRs that showed a greater than 4 fold increase in RNA level are listed. The
genes are categorized into their family names (based roughly on IUPHAR
categories), and their fold change is indicated. The data represent the average
of the results from two independent experiments.
doi:10.1371/journal.pone.0009105.t002
Table 3. GPCRs that were down-regulated in day 20
compared to day 4 EBs.
Family Gene Fold Change
Chemokine Ccr2 0.04
Cxcr4 0.04
Ccr7 0.14
Lysophospholipid Edg4 0.01
Edg5 0.01
Thrombin F2rl1 0.01
Frizzled Fzd5 0.01
Endothelin Ednra 0.01
Glucagon Glp1r 0.25
Gcgr 0.04
Orphans Gpr103 0.01
Gpr41 0.09
Gpr108 0.01
Gpr1 0.07
Gpr124 0.25
Gpr135 0.22
Gpr133 0.01
Gpr146 0.04
CD97 0.01
Leukotriene Mass1 0.07
Somatostatin Sstr3 0.07
Prostanoid Tbxa2r 0.21
Free fatty acid Ffar1 0.12
GPCRs that showed a greater than 4 fold decrease in RNA level are listed. The
genes are categorized into their family (based roughly on IUPHAR categories),
and their fold change is indicated. The data represent the average of the results
from two independent experiments.
doi:10.1371/journal.pone.0009105.t003
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different sample preparations were stained for both Nanog and
DAPI, and the number of Nanog
+ cells relative to DAPI
+ cells was
determined. Images covering the slide were obtained and
systematically counted to determine the ratio of Nanog
+/DAPI
+
cells by an individual blinded to the experimental conditions and
expected outcomes. The data are presented as an average of the
percentage of Nanog
+ cells relative to DAPI
+ cells for each slide
(average of three separate slides counted for each condition). A
similar approach was used to determine the number of Ki67
+ cells
in EBs treated or not with CTX. Slides from three randomly-
selected sections from different sample preparations were stained
for both Ki67 and DAPI and the number of Ki67
+ cells relative to
DAPI
+ cells in each section was determined.
WST-1 Assay
EBs were isolated at the indicated time points, washed once with
PBS, and resuspended in PBS with WST-1 (Roche, Hannheim,
Germany). The EBs were then incubated and analyzed according
to the manufacturer’s instructions. Metabolically active cells were
quantified by following absorbance at A450 [26].
Statistical Analyses
Values are reported as the mean 6 SEM. P values were
calculated by Student’s t-test with a significance level at P,0.05
using SigmaStat 3.1 software (SYSTAT Software, Inc., Rich-
mond, CA).
Figure 3. Verification of GPCR mRNA levels using real time RT-PCR. (A–B) Relative changes in the level of mRNA encoding MC4R and
SSTR1(A) and the EDG4 and GLP-1 receptors (B) in day 20 compared to day 4 EBs, as determined by real time RT-PCR (mean 6 SEM, n=3 or 4). (C)
Western blot analysis of MC4R protein expression (representative of the results from three independent experiments) in extracts of day 4 (D4) and
day 20 (D20) EBs. Following hybridization with antibodies directed against the above receptors, the blots were stripped and re-probed with antibody
against GAPDH.
doi:10.1371/journal.pone.0009105.g003
Table 4. The 15 GPCRs that exhibited the largest change in
expression in day 4 EBs compared to undifferentiated ES cells.
Gene Fold Change
Gpr133 1417
Ccr2 683
Cxcr4 278
Gpr26 247
Fzd6 242
Adra2b 210
Fzd2 149
Gpr23 138
Mass1 137
Oprd1 122
Adora1 121
Sstr3 117
Vipr2 85
Adra2a 76
Ppyr1 75
The data represent the average of the results from two independent
experiments.
doi:10.1371/journal.pone.0009105.t004
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GPCRs Expression in ES Cells
Initial studies examined the differential expression of GPCRs in
ES cells from day 4 and 20 EBs. EBs at day 4 contain mostly
undifferentiated ES cells as compared to day 20 EBs. This is
evident by comparing the level of expression of mRNA encoding
Nanog and Oct4 in day 4 EBs and undifferentiated ES cells. The
levels were essentially the same, while by day 20, the level of
mRNA encoding Nanog and Oct4 had decreased significantly
compared to the level in day 4 EBs. In contrast, between day 4 and
day 20, the expression of mRNAs characteristic of the three germ
layers increased (Figure 1A–B).
To profile the expression of mRNAs encoding 343 non-odorant
GPCRs in ES cells at day 4 and 20, a real time RT-PCR GPCR-
specific microarray was used (see Text S1 for the list of GPCR
genes in the array and Text S2 for the raw expression data). To
categorize the general expression level of the different genes,
RNAs were assigned to one of the following groups: undetectable
(see Methods for description), low (cycle number .31.0), moderate
(cycle number between 31.0 to 28.0), and high (cycle number less
than 28.0) expression. The ranges for these categories were defined
based on the knowledge that frizzled receptors (Fzd 1–10) are
expressed in mouse as well as in human ES cells [27]. The mean
cycle number of Fzd receptors 1–10 in our microarray data from
day 4 EBs were 30.8, 28.6, 29.2, 31.4, 28.0, 28.4, 25.5, 28.7, 34.7,
and 28.5 (n=2), respectively. We arbitrarily defined our categories
to have a majority of these Frizzled receptors in the moderate to
high expression level. As seen in Figure 2A, 161 and 148 receptors
exhibited low expression at day 4 and day 20, respectively, and 30
and 31 receptors exhibited moderate expression at day 4 and day
20, respectively. At day 4, 7 receptors were in the high expression
category. At day 20, 23 were in the high expression category. 145
and 141 receptors were undetectable at day 4 and day 20,
respectively.
The 15 receptors with the highest level of expression in EBs on
days 4 and 20 are shown in Fig. 2B and 2C. On day 4, five frizzled
receptors (Fzd7, Smo, Fzd5, Fzd6, and Fzd10) and, on day 20,
three frizzled receptors (Smo, Fzd7, Fzdb) were highly expressed.
The function of the other highly expressed receptors in day 4 and
20 EBs is not clear. Among the 15 most highly expressed receptors,
seven (Lpn1, Gabbr1r, Crcp, Fzd7, F2r, Pthr1, Smo, P2ry5)
receptors were highly expressed at both day 4 and day 20.
Although some receptors were highly expressed at both time
points, many receptors demonstrated a dramatic difference in
expression between day 4 and day 20. Receptors which were up-
or down-regulated between day 4 and 20 are listed in Tables 2 and
3, respectively.
Real time RT-PCR was used to verify the change in expression
level of some of these receptors. As seen in Fig. 3, MC4R and
Figure 4. Gs-alpha is expressed and functional in mouse ES cells forming EBs. (A) Representative immunoblot of Gs-alpha expression in
extracts of day 4 (D4) and day 20 (D20) EBs. The findings are representative of the results of three independent experiments. After hybridization, the
blots were stripped and re-probed with antibody against GAPDH. (B–C) Immunohistochemical localization of Gs-alpha in EBs. Day 4 (B) and day 20 (C)
EBs were immunostained with an antibody to Gs-alpha (red), and nuclei were stained with DAPI (blue), magnification was 406. (D) Immunoblot of
phospo-CREB in day 4 EBs treated with 1 mg/ml CTX for 0, 5, 15, 30 and 60 mins, as well as 4 days. Immunoblots for total CREB and GAPDH using the
same samples are also shown. The results are representative of the results from 3 independent experiments.
doi:10.1371/journal.pone.0009105.g004
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while LPA2, GPR108, and GLP-1 receptor mRNA levels were
down regulated (Fig. 3B). These changes are consistent with those
observed in the microarray experiments. To determine if these
changes in mRNA levels were reflected by a change in the level of
protein, Western blot analyses were performed to examine the
protein levels for one of these receptors, MC4R. Consistent with
the change in mRNA level, the expression of MC4R was increased
in day 20 compared to day 4 EBs (Fig. 3C).
Because some cells in day 4 EBs have likely undergone some
degree of differentiation, as reflected by the increased level of an
mRNA encoding a protein characteristic of endoderm in day 4
EBs compared to undifferentiated ES cells (Figure 1B), we
performed a similar analysis on undifferentiated ES cells grown
in a feeder free system. Overall, the relative expression of the
GPCRs was much lower in undifferentiated ES cells than in day 4
and 20 EBs. Using the classification scheme in Figure 2A for the
undifferentiated ES cells, no GPCRs were in the high expression
group, 1 GPCR was in the moderate expression group, and 100
were in the low expression group. The remaining GPCRs were not
detectable. No GPCRs exhibited increased expression (greater
than 4 fold) in undifferentiated ES cells compared to day 4 EBs.
The 15 GPCRs exhibiting the largest increase in day 4 EBs
compared to undifferentiated ES cells are shown in Table 4.
When comparing the 15 GPCRs that were the mostly highly
expressed in undifferentiated ES cells and day 4 EBs, 12 of the 15
receptors were the same (Figure 2D). Three receptors; TM7sf3,
Cesr1, and CD97l, were among the 15 most highly expressed
GPCRs in undifferentiated ES cells but not day 4 EBs. However,
each of these receptors were expressed at relatively high levels in
day 4 EBs (among the top 40 receptors overall). Similarly, the
GPCRs that were among the 15 most highly expressed receptors
in day 4 EBs and not in this group in undifferentiated ES cells
(Gpr125, PTH1r and Fzd6) were all expressed in undifferentiated
ES cells. In general, GPCR expression in undifferentiated ES cells
and day 4 EBs was similar (see Text S2 for the undifferentiated ES
cell raw expression data).
Searching expressed sequence tag (EST) databases is an
alternative in silico approach for examining expression profiles of
GPCRs. To further support the results of our microarray analyses,
we examined the expression of GPCRs in a database generated by
Cloonan et al., which included libraries from undifferentiated
mouse ES cells and EBs at day 4 of formation. Examination of the
Gene Expression Omnibus (GEO) database (GSE10518) for the
343 GPCRs assayed in our real time RT-PCR microarray
demonstrated that 30 were present in the GEO database
(Table 5). All of these receptors were also detected using the
GPCR microarray in day 4 EBs. Most receptors that were
detected by this data mining approach were in the moderate and
high expression categories as determined in the real time RT-PCR
microarray. Interestingly, these same 30 receptors were also
present in a human ES cell EST database [28]. These data also
demonstrate good overlap with our GPCR expression data in
undifferentiated ES cells. Of the 17 GPCRs in the GEO database
which were reported to be expressed only in undifferentiated ES
cells, 15 were detected by the GPCR microarray using the
undifferentiated ES cells (missing were Gpr19 and Gpr23).
Gs-Alpha Signaling in Mouse ES Cells
Having established that multiple GPCRs are expressed in ES
cells and some are differentially expressed during differentiation,
we next sought to investigate the role of Gs-alpha signaling
pathways in differentiating ES cells. Prior to investigating the
effects of CTX on ES cells, Gs-alpha expression and function in
the ES cells was confirmed. Western blot analyses demonstrated
that Gs-alpha is expressed in differentiating ES cells during EB
formation with expression evident in EBs at both day 4 and 20
(Fig. 4A). Further, immunohistochemical analyses demonstrated
Gs-alpha expression in most cells within EBs at day 4 and 20 with
no evidence for regional localization of expression within the EBs
(Fig. 4B and 4C). To verify that the Gs-alpha pathway is functional
in differentiating ES cells, EBs were treated with 1 mg/ml CTX,
which is a toxin that ADP-ribosylates Gs-alpha, resulting in
permanent activation of Gs-alpha, cAMP generation, and,
ultimately, activation of the transcription factor, cAMP-response
element binding protein (CREB). The response of the ES cells to
CTX was tested by examining CREB phosphorylation in day 4
EBs. As seen in Fig. 4D, CTX treatment of day 4 EBs increased
CREB phosphorylation, consistent with the presence of a
functional Gs-alpha pathway. Next, we examined the impact of
CTX treatment on EB morphology. We found that EBs treated
with CTX were consistently larger than control, untreated EBs
between days 4 and 20 (Fig. 5A-D). When the diameter of the EBs
was determined, a significant increase in the diameter of CTX-
treated compared to control EBs was observed (Fig. 5E). Because
this finding could reflect CTX leading to increased EB aggregation
and, thus, larger EBs, we explored this possibility by growing
individual EBs using the hanging drop method [24]. As is
apparent, when this method was used, a similar trend toward
larger EBs was seen in the CTX–treated compared to control
group (Fig. 5F).
Because the results of the above studies suggest that EBs grown
in the presence of CTX are larger, we examined whether cell
proliferation was increased in CTX-treated compared to control
EBs. To do this, two complementary approaches were used. First,
the WST-1 assay, an indicator of metabolic activity and,
Table 5. Data mining of a whole genome RNA expression
library (GSE10518) from ES cells at day 0 and day 4 of EB
formation for GPCRs*.
Day 0 Day 0 & Day 4 Day 4
Cd97 (l,h,u) Celsr3 (l,h,h) Adcyap1r1 (l,m,h)
Tm7sf3 (l,h,h) Crcp (l,h,h) Adra2a (u,m,h)
Fzd5 (l,h,l) Edg2 (l,h,h) Adra2b (u,m,m)
Gabbr1 (l,h,h) Edg4 (l,h,l) Ednra (l,l,u)
Edg5 (l,h,u) Frzb (l,m,h)
F2r (l,h,h) Lgr5 (u,l,m)
F2rl1 (l,l,h) Prokr1 (l,l,l)
Fzd7 (m,h,h) Pthr1 (l,h,h)
Gpr108 (l,l,h) Agtrl1 (u,l,m)
Gpr125 (l,h,h) Celsr1 (l,h,h)
Gpr137 (l,h,h) Cxcr4 (u,m,l)
Gpr19 (u,l,u) Fzd3 (l,h,h)
Gpr23 (u,m,m) Gpr124 (l,h,m)
*Day 0 represents undifferentiated ES cells prior to EB formation and Day 4
represents EBs analyzed at day 4 of EB formation. This database was mined for
the GPCRs included in the real time RT-PCR array (see Text S2). Receptors were
identified as expressed at day 0 alone, day 0 and day 4 both or day 4 alone. In
parenthesis, next to each gene name is the corresponding expression level
determined by the GPCR specific real time RT-PCR microarray for
undifferentiated ES cells and day 4 and day 20 EBs (h= high, m= medium,
l= low, and u= undetectable).
doi:10.1371/journal.pone.0009105.t005
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treated EBs over 20 days exhibited increased metabolic activity
compared to control EBs. Next, an immunohistochemical analysis
was used to compare the expression of Ki67, a marker of cell
proliferation, in CTX-treated and control day 20 EBs. As is
apparent, the percentage of Ki67-positive cells in the EBs was
higher in the CTX-treated compared to control EBs at day 20
(Figure 6B–D). Overall, these data suggest that CTX leads to
increased cell proliferation in EBs.
To determine whether Gs-alpha activation had an effect on the
expression of proteins characteristic of pluripotent and differen-
tiating ES cells in EBs, the effect of CTX treatment on the
expression of markers of pluripotency and differentiation was
examined. As described in the Methods, ES cells were grown in
suspension culture for EB formation either in the presence or
absence of CTX. For these studies, RNA was extracted from
control and CTX-treated EBs at different time points between
days 12 and 20, and the expression of mRNAs encoding proteins
important for ES cell pluripotency or differentiation was quantified
by real time RT-PCR. As can be seen in Fig. 7, the level of mRNA
encoding transcription factors important for pluripotency, Nanog
(Fig. 7A) and Oct4 (Fig. 7B), was increased in CTX-treated
compared to control EBs at each time point.
As the change in the level of Nanog mRNA was more
pronounced, subsequent studies focused on determining whether
the change in Nanog mRNA levels was accompanied by a change
in protein levels. Western blot analyses using protein lysates from
control and CTX-treated EBs harvested at time points between
day 4 and 20 demonstrated a decline in Nanog levels in control
EBs while Nanog expression in CTX-treated EBs tended to be
maintained (Fig. 7C). This trend of a greater decline in Nanog in
the control EBs as compared to the CTX-treated EBs is also
reflected in the RNA expression as seen in the cycle number (mean
6 SD) at each of these time points (day 12 control vs CTX,
27.860.3 vs 28.260.2; day 16 control vs CTX, 32.861.0 vs
26.760.3; day 20 control vs CTX, 32.560.6 vs 27.660.7).
Overall, Nanog mRNA and protein levels were relatively stable
between day 12 and 20 in the CTX treated group, while declining
in control EBs during this same time period. Immunohistochem-
ical analyses demonstrated that the number of Nanog
+ cells was
increased in CTX-treated compared to control EBs in day 20 EBs
(Fig. 7D–F). Taken together, the results of the above studies
Figure 5. The effect of Gs-alpha activation by CTX on EB size. (A–D) EB formation in the absence (A,C) or presence (B,D) of 1 mg/ml CTX at day 4
(A,B) and day 12 (C,D). (E) A comparison of the diameter (mean 6 SEM) of EBs incubated in the absence (blue bars) and presence (red bars) of 1 mg/ml
CTX over a 20 day period. One random image was taken of each sample of EBs, and the greatest horizontal diameter for each EB in the horizontal plane
was measured. A total of 4 to 9 (independently prepared) EB preparations were studied at each time point. *, P,0.05 compared to control, untreated EBs.
Total number of EBs counted for each condition was for day 4 (control, CTX; 417, 395), day 8 (346, 195), day 12 (255, 129), day 16 (58, 50) and day 20 (36,
25). (F) A comparison of the diameter (mean 6 SEM) of EBs produced by the hanging drop method and incubated in the absence (n=10 at each time
point, blue bars) and presence (n=11 at each time point, red bars) of 1 mg/ml CTX over a 20 day period. An image was taken on each individually grown
EB, and the greatest horizontal diameter for each EB in the horizontal plane was measured. *, P,0.05 compared to control, untreated EBs.
doi:10.1371/journal.pone.0009105.g005
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expression of transcription factors important for pluripotency in
ES cells.
The expression of markers of early differentiation was also
examined by real time RT-PCR. The level of mRNAs encoding
proteins present in cells differentiating along ectodermal (E-
Cadherin), mesodermal (Brachyury, Mixl1), and endodermal
(Sox17, Fox2a and CXCR4) pathways demonstrated no substan-
tial difference in CTX-treated compared to control EBs between
12 and 20 days (Figure S1).
Discussion
To explore the expression profile of GPCRs in ES cells, two
main approaches were used, real time RT-PCR microarrays and
data mining of EST libraries specific to ES cells. Interestingly,
GPCRs represent only a small portion of the genes in ESTs
relative to their representation in the whole genome [29]. Thus,
these databases are thought to under represent the number of
expressed GPCRs [27]. By examining an EST database created
from mostly undifferentiated ES cells, 30 GPCRs were detected
(Table 5). All of these receptors were also expressed in our real
time RT-PCR microarrays at one of the time points evaluated in
our study (undifferentiated ES cells or EBs at day 4 and day 20).
The in silico data alone indicate that multiple GPCRs are
expressed in ES cells. But, as noted, this probably under represents
the GPCRs expressed in ES cells. Indeed, our real time RT-PCR
microarray data demonstrate that a large number of GPCRs are
expressed not only in undifferentiated ES cells but in differenti-
ating ES cells in EBs as well. Moreover, a large number of these
GPCRs are differentially expressed during ES cell differentiation
in EBs. Interestingly, there is much lower overall expression of
GPCRs in undifferentiated ES cells as compared to EBs at either
day 4 or day 20. Despite these differences, the particular GPCRs
that are expressed in undifferentiated ES cells are similar to those
in day 4 EBs. Taken together, these findings demonstrate that a
broad range of GPCRs are expressed in ES cells and likely play an
important role in ES cell biology.
Based on previous embryological data, a number of the
GPCRs were expected to be expressed at higher levels during the
course of ES cell differentiation in EBs. For example, on day 4,
two receptors from the proteinase-activated receptor family
(PAR), F2r and F2rl1, were highly expressed. F2r, also known
as PAR1, has been shown to have an important role in early
embryonic development, as global knockout results in lethality at
mid-gestation due to bleeding complications [15]. Another
receptor that was highly expressed in our assays, GPR125, has
been identified as a marker of germ-line progenitors [27,30],
although its role in ES cell differentiation is not clear. LGR4,
another of the identified receptors, has a demonstrated role in
Figure 6. Effect of Gs-alpha activation on cell proliferation in EBs. (A) Cell metabolic activity in EBs over a 20 day period of CTX treatment
was evaluated, and the percentage change in the CTX-treated compared to control cells was determined in three independent samples at each time
point. The values represent the relative percentage change in absorbance A450 in the CTX-treated EBs as compared to the control EBs, and the
percentage change is shown. *, P,0.05 compared to control, untreated EBs. (B) The percentage of Ki67
+ cells in CTX-treated and control EBs at day 20
relative to DAPI
+ positive cells was determined as described in the Methods.* ,P,0.05 compared to control cells. Representative image of
immunohistochemical localization of Ki67 (red) in control (C) and CTX-treated (D) day 20 EBs is shown. EBs were immunostained with an antibody to
Ki67, and nuclei were stained with DAPI (blue).
doi:10.1371/journal.pone.0009105.g006
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2/2 mice had decreased survival with
most offspring dying by day 2 and exhibiting intrauterine growth
retardation and abnormalities in kidney and liver development
[31]. Even though the expression of these receptors is predicted
in ES cells based on previous studies of development, the role of
these GPCRs in mediating ES cell differentiation has not been
specifically explored. The potential role of these and many
GPCRs that were found to be expressed in ES cells warrants
further study.
Activation of Gs-alpha by CTX consistently led to larger EBs
over time. This effect is related, in part, to an increase in cell
proliferation in CTX-treated compared to control EBs. One of the
primary signaling pathways activated by Gs-alpha is the cAMP
pathway. The role of cAMP in regulating proliferation in different
cell lines has been previously studied. Interestingly, the effect of
cAMP on proliferation is known to be cell type dependent
[32,33,34]. In this study the overall effect of Gs-alpha activation
and, presumably, the cAMP pathway was increased cell
proliferation in the EBs. As cell differentiation along multiple
different lineages occurs in the context of EBs, it is not clear at
present whether the effect of CTX on cell proliferation was limited
to undifferentiated or differentiating ES cells or was realized in
both cell types. This will need to be addressed in future studies.
Our finding that Gs-alpha impacts the expression of transcrip-
tion factors important for ES cell pluripotency is not unexpected
considering the diverse roles of cAMP in multiple cell types. It
should be noted that the possibility that the Gs-alpha pathway may
be involved in the regulation of ES cell pluripotency has been
suggested before. Specifically, a previous study in ES cells
suggested a role for cAMP in ES cell self renewal [35]. Our
finding that CTX induced the phosphorylation of CREB in ES
cells suggests that Gs-alpha signaling activates the cAMP pathway
in ES cells. Thus, the present study further supports the idea that
the Gs-alpha-cAMP cascade may contribute to the maintenance of
ES cell pluripotency.
Because GPCR signaling has received little attention in ES cells,
this study reports the first direct exploration of G protein signaling
and GPCR expression in ES cells. Expression profiling of GPCRs
in ES cells demonstrated expression of a large number of GPCRs
whose role in ES cell biology remains largely uninvestigated.
Hundreds of GPCRs exist, but they signal through only 20 alpha
subunits. Thus, one approach to examine GPCR signaling is to
Figure 7. Effect of Gs-alpha activation on Nanog and Oct4 expression. (A–B) Fold changes in the level of Nanog (A) and Oct4 (B) mRNA in
CTX-treated compared to control EBs at day 12, 16, and 20 as determined by real time RT-PCR. Values are the mean 6 SEM (n=3 for Nanog and n=4
for Oct4). (C) Western blot analysis of Nanog expression in CTX-treated (X) compared to control cells (C) at different time points (D4, D8, D12, D16,
D20). The blots were stripped and re-probed for GAPDH. The results are representative of the results of three independent experiments. (D–E)
Immunohistochemical localization of Nanog (red) in control (D) and CTX-treated (E) day 20 EBs. EBs were immunostained with an antibody to Nanog
(red), and nuclei were stained with DAPI (blue). The images are representative of the results of three independent experiments. (F) The percentage of
Nanog
+ cells in CTX-treated and control EBs at day 20 relative to DAPI
+ positive cells was determined as described in the Methods.* ,P,0.05
compared to control cells.
doi:10.1371/journal.pone.0009105.g007
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this rationale, we examined the impact of signaling through Gs-
alpha on ES cells and report for the first time that the Gs-alpha
pathway is present, functional in ES cells, increases ES cell
proliferation, and impacts the expression of transcription factors
important for ES cell pluripotency. This initial examination of
GPCR expression and signaling in ES cells suggests a potentially
important role for this family of receptors in ES cell biology. More
broadly, these data indicate that this important class of signaling
molecules needs to be further explored in ES cells as their
activation may be important for modulating ES cells differentia-
tion and the development of ES cell based therapies.
Supporting Information
Figure S1 Level of mRNAs encoding proteins characteristic of
ectoderm, endoderm and mesoderm. Relative changes (means
6SEM) in the level of mRNA encoding: (A) E-Cadherin (n=3),
(B) Brachyury (n=4, blue bars) and SOX17 (n=2, red bars), and
(C) MIXL1 (n=2, blue bars), CXCR4 (n=3, red bars), and
FOX2a (n=3, yellow bars) in CTX-treated compared to control
EBs at day 12, 16, and 20, as determined by real time RT-PCR.
Found at: doi:10.1371/journal.pone.0009105.s001 (0.08 MB TIF)
Text S1 A list of the GPCR genes in the real time RT-PCR
microarray.
Found at: doi:10.1371/journal.pone.0009105.s002 (0.03 MB
XLS)
Text S2 Raw expression data for the GPCR genes in the array.
Found at: doi:10.1371/journal.pone.0009105.s003 (0.07 MB
XLS)
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